Bioasis Technologies (OTCMKTS:BIOAF) Shares Down 12.5%

Shares of Bioasis Technologies Inc. (OTCMKTS:BIOAFGet Rating) were down 12.5% on Tuesday . The stock traded as low as $0.14 and last traded at $0.14. Approximately 101,000 shares traded hands during mid-day trading, an increase of 424% from the average daily volume of 19,291 shares. The stock had previously closed at $0.16.

The business has a 50-day moving average price of $0.18 and a 200 day moving average price of $0.20.

About Bioasis Technologies (OTCMKTS:BIOAF)

Bioasis Technologies Inc, a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the delivery of therapeutics across the blood-brain barrier (BBB); and the treatment of central nervous system disorders, including brain cancers, and metabolic and neurodegenerative diseases.

Featured Stories

Receive News & Ratings for Bioasis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioasis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.